@article{CJCR2557,
author = {Disheng Yang and Shunwu Fan and Huimin Tao and Rongxin He and Zhaoming Ye and Fang Zhou and Wenlong Zhan and Zongjian Huang},
title = {SOLITARY PLASMACYTOMA OF BONE AND EXTRAMEDULLARY PLASMACYTOMA},
journal = {Chinese Journal of Cancer Research},
volume = {8},
number = {4},
year = {2013},
keywords = {},
abstract = {Among plasma cell disorders, solitary plasmacytoma (solitary-plasmacytoma of bone, SPB and extramedullary plasmacytoma, EMP) is rare as compared with mulitiple myeloma (MM). Furthermore, the relationship between solitary plasmaeytoma and MM remains unclear. Between 1960 and 1994, 24 patients with SPB and 20 with EMP were treated. The criteria for diagonosis were: (1) No evidence of other lesions based on clinical and radiologic examinations; (2) Biopsy evidence of a plasma cell neoplasm; (3) Bone marrow biopsy specimen with negative findings (less than 10% plasma cell); (4) No anemia, hypercalcemia or renal involvement. The average follow-up period was 112 months (from 6 to 360 months). Fifty-four percent of patients with SPB and 40% of patients with EMP developed MM, however, there was no significant statistical difference between SPB and EMP (P },
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/2557}
}